Tauriga Sciences Inc. Enters into 6 Month Agreement with Coalition Technologies to Enhance its Search Engine Optimization Metrics
Tauriga Sciences, Inc. (OTCQB: TAUG) has entered a 6-month agreement with Coalition Technologies to improve its SEO metrics. The aim is to enhance brand awareness of Tauri-Gum™ and boost e-commerce sales. With a positive industry outlook, the company plans to allocate part of its marketing budget to SEO efforts. Additionally, the recent increase in CBD & CBG infusion concentrations (25mg per piece) is expected to attract more e-commerce customers. Tauriga is also engaged in pharmaceutical development for a medicated version of Tauri-Gum™.
- 6-month agreement with Coalition Technologies to enhance SEO metrics.
- Focus on increasing brand awareness and e-commerce sales for Tauri-Gum™.
- Higher concentration of CBD & CBG (25mg) expected to attract more customers.
- None.
The Company is Focused on Both Increasing Tauri-Gum™ Brand Awareness and E-Commerce Revenue
NEW YORK, NY, March 19, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of CBD & CBG infused Supplement chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant), additional product offerings, as well as an ongoing Pharmaceutical Development initiative, today announced that it has entered into a 6 month agreement (the “Agreement”) with Coalition Technologies, to enhance its Search Engine Optimization (“SEO”) metrics. The Company’s goal is to both enhance the brand awareness of its flagship Tauri-Gum™ brand as well as increase its E-Commerce sales. Due to the more favorable macro-industry outlook, the Company believes that the timing is prudent – to allocate a % of its marketing budget on SEO services and strategies.
Additionally, the Company is confident that its existing infrastructures enable it to efficiently and effectively monetize any material future improvements to its SEO metrics. The Company also believes that its recent decision to increase the Tauri-Gum™ CBD & CBG infusion concentrations (25mg / per piece of chewing gum) will broaden its prospective E-Commerce customer base.
ABOUT TAURIGA SCIENCES INC.
Tauriga Sciences, Inc. (TAUG) is a revenue generating, diversified life sciences company, engaged in several major business activities and initiatives. The company manufactures and distributes several proprietary retail products and product lines, mainly focused on the Cannabidiol (“CBD”) and Cannabigerol (“CBG”) Edibles market segment. The main product line, branded as Tauri-Gum™, consists of a proprietary supplement chewing gum that is Kosher certified, Halal certified, and Vegan Formulated (CBD Infused Tauri-Gum™ Flavors: Mint, Blood Orange, Pomegranate), (CBG Infused Tauri-Gum™ Flavors: Peach-Lemon, Black Currant) & (Vitamin C + Zinc “Immune Booster” Flavor: Pear Bellini). The Company’s commercialization strategy consists of a broad array of retail customers, distributors, and a fast-growing E-Commerce business segment (E-Commerce website: www.taurigum.com). Please visit our corporate website, for additional information, as well as inquiries, at http://www.tauriga.com
Complementary to the Company’s retail business, is its ongoing Pharmaceutical Development initiative. This relates to the development of a proposed Pharmaceutical grade version of Tauri-Gum™, for nausea regulation (specifically designed for the following indication: Patients Subjected to Ongoing Chemotherapy Treatment). On March 18, 2020, the Company announced that it had filed a provisional U.S. patent application covering its pharmaceutical grade version of Tauri-Gum™. The Patent, filed with the U.S.P.T.O. is Titled “MEDICATED CBD COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS OF TREATMENT”. On December 18, 2020 the Company disclosed that it had entered into a Master Services Agreement with CSTI to lead the Company's clinical development efforts.
The Company is headquartered in Wappingers Falls, New York. In addition, the Company operates two full time E-Commerce fulfillment centers: one located in Montgomery, Texas and the other in Brooklyn, New York.
DISCLAIMER -- Forward-Looking Statements
This press release contains certain “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995 which represent management’s beliefs and assumptions concerning future events. These forward-looking statements are often indicated by using words such as “may,” “will,” “expects,” “anticipates,” believes, “hopes,” “believes,” or plans, and may include statements regarding corporate objectives as well as the attainment of certain corporate goals and milestones. Forward-looking statements are based on present circumstances and on management’s present beliefs with respect to events that have not occurred, that may not occur, or that may occur with different consequences or timing than those now assumed or anticipated. Actual results may differ materially from those expressed in forward looking statements due to known and unknown risks and uncertainties, such as are not guarantees of general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to consummate successful acquisition and licensing transactions, fluctuations in exchange rates, and other factors over which Tauriga has little or no control. Many of these risks and uncertainties are discussed in greater detail in the “Risk Factors” section of Tauriga’s Form 10-K and other periodic filings made from time to time with the Securities and Exchange Commission. Such forward-looking statements are made only as of the date of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. You should not place undue reliance on these forward-looking statements.
Contact:
Tauriga Sciences, Inc.
4 Nancy Court, Suite 4
Wappingers Falls, NY 12590
Chief Executive Officer
Mr. Seth M. Shaw
Email: sshaw@tauriga.com
cell # (917) 796 9926
Company Instagram: @taurigum
Personal Instagram: @sethsms47
Twitter: @SethMShaw
Corp. Website: www.tauriga.com
E-Commerce Website: www.taurigum.com
FAQ
What is the purpose of Tauriga Sciences' agreement with Coalition Technologies?
What products does Tauriga Sciences offer?
How does Tauriga Sciences plan to enhance its e-commerce sales?
What recent change did Tauriga make to its Tauri-Gum™ product?
What is Tauriga Sciences' ongoing pharmaceutical development initiative?
